Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,978 public trials 1,830 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Heparin or Enoxaparin in Patients With Cancer

NCT00004875

Conditions: Burkitt Lymphoma, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States

Evanston Northwestern Health Care Evanston, Illinois, United States

View Trial Details

Completed

Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

NCT00005619

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage

NCT00248443

Conditions: Acute Respiratory Failure, Cancer, Hematologic Diseases, +9 more
Locations: Service de Réanimation Médicale de l'Hôpital Saint-Louis Paris, France

View Trial Details

Completed

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

NCT00772811

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +23 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

NCT00168012

Conditions: Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +8 more
Locations: Not specified

View Trial Details

Completed

SPC2996 in Chronic Lymphocytic Leukaemia

NCT00285103

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Holden Comprehensive Cancer Center, Univ. of Iowa Iowa City, Iowa, United States

Rigshospitalet Copenhagen, Denmark

KAS Herlev Herlev, Denmark

Vejle Sygehus Vejle, Denmark

View Trial Details

Completed

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma

NCT00509379

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Ospedale Cardinale Panico Tricase, Lecce, Italy

Istituto Clinico Humanitas Rozzano, Milano, Italy

Istituto per la ricerca e la cura del cancro Candiolo, Torino, Italy

Ospedale Civico Chivasso, Torino, Italy

View all 22 locations

View Trial Details

Completed

Gemini Symbicort pMDI

NCT00646516

Conditions: Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections

NCT00597090

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Persistent Pain After Breast Cancer Treatment With Docetaxel

NCT01279018

Conditions: Breast Diseases, Breast Neoplasms, Hemic and Lymphatic Diseases, +17 more
Locations: Not specified

View Trial Details